Recent Updates
Recently added Catalysts
ILMN Positive Sentiment Score: 75/100

Illumina to Present Upcoming Strategy Update As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24, the company will present a Strategy Update on Tuesday, August 13, 2024 starting at...

Thursday, July 18, 2024 2 min read
Key Takeaway: Illumina, Inc. (NASDAQ: ILMN) has announced a Strategy Update event to take place on August 13, 2024. This event will include presentations from members of Illumina's executive team and will conclude with a Q&A session. Investors can access a webcast of the event through the company's Investor Relations website, and a replay will be available for 30 days post-event. The company continues to focus on innovation in genomic technologies, aiming to improve human health across various sectors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Illumina is set to present a Strategy Update, indicating proactive planning.
  • The event will feature presentations from Illumina's executive team, showcasing leadership and innovation.
  • The company emphasizes its role as a leader in DNA sequencing and technology, highlighting its market strength.

Full Press Release Details

SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN ) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at 8:00am Pacific Time . The event will feature presentations by members of Illumina's executive team and conclude with a Q&A session.
Webcast Details
The webcast can be accessed through the Events & Presentations section of Illumina's Investor Relations website at investor.illumina.com . We recommend that participants pre-register for the event on our website or using the following link: Illumina 2024 Strategy Update Registration . A replay will be posted on Illumina's Investor Relations website after the event and will be available for at least 30 days following.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter) , Facebook , LinkedIn , Instagram , TikTok , and YouTube
Investors: Salli Schwartz +1.858.291.6421 [email protected]
Media: Bonny Fowler +1.740.641.5579 [email protected]
SOURCE Illumina, Inc.

21 %

Frequently Asked Questions

When is Illumina's Strategy Update presentation scheduled?

It is scheduled for August 13, 2024, at 8:00 am Pacific Time.

How can I access the webcast for Illumina's event?

The webcast can be found in the Events & Presentations section of Illumina's Investor Relations website.

Will there be a Q&A session during the Strategy Update?

Yes, the event will conclude with a question and answer session.

How long will the replay of the event be available?

The replay will be available for at least 30 days post-event.

What areas does Illumina focus on in its technologies?

Illumina focuses on DNA sequencing and array-based technologies across various markets.

Tags: ILMN Viatris Investor Conferences Healthcare Illumina DNA sequencing genome NASDAQ: ILMN health innovation
Last updated: Jul 18, 2024